NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 41 filers reported holding NYMOX PHARMACEUTICAL CORP in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $3,876 | -44.1% | 20,400 | 0.0% | 0.00% | – |
Q1 2023 | $6,936 | -0.9% | 20,400 | 0.0% | 0.00% | – |
Q4 2022 | $7,000 | +133.3% | 20,400 | +155.0% | 0.00% | – |
Q3 2022 | $3,000 | 0.0% | 8,000 | 0.0% | 0.00% | – |
Q2 2022 | $3,000 | -70.0% | 8,000 | 0.0% | 0.00% | – |
Q1 2022 | $10,000 | 0.0% | 8,000 | 0.0% | 0.00% | – |
Q4 2021 | $10,000 | -60.0% | 8,000 | -33.9% | 0.00% | – |
Q3 2021 | $25,000 | +525.0% | 12,100 | +365.4% | 0.00% | – |
Q2 2021 | $4,000 | -33.3% | 2,600 | 0.0% | 0.00% | – |
Q1 2021 | $6,000 | -40.0% | 2,600 | -38.1% | 0.00% | – |
Q4 2020 | $10,000 | -16.7% | 4,200 | -16.0% | 0.00% | – |
Q3 2020 | $12,000 | -71.4% | 5,000 | -58.0% | 0.00% | – |
Q2 2020 | $42,000 | +250.0% | 11,900 | +138.0% | 0.00% | – |
Q1 2020 | $12,000 | – | 5,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MARATHON CAPITAL MANAGEMENT | 55,000 | $179,000 | 0.09% |
WEDBUSH SECURITIES INC | 180,945 | $590,000 | 0.09% |
Brown Advisory Securities, LLC | 28,000 | $91,000 | 0.03% |
FNY Managed Accounts LLC | 8,000 | $26,080,000 | 0.02% |
FT Options LLC | 10,000 | $26,000 | 0.02% |
WEBSTER BANK, N. A. | 40,000 | $130,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 30,907 | $101,000 | 0.01% |
GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $82,000 | 0.00% |
NATIONAL PLANNING CORP | 11,000 | $32,000 | 0.00% |
Virtu KCG Holdings LLC | 24,705 | $81,000 | 0.00% |